Inside Innovation

A 15-year follow-up analysis led by researchers at Fred Hutch Cancer Center suggests that follicular lymphoma may be curable for some patients treated with chemoimmunotherapy.

Researchers from Weill Cornell Medicine and the Allen Institute have discovered that pain-sensing neurons in the gut help coordinate the immune system’s response to intestinal

Fred Hutch Cancer Center scientists have developed genetically human monoclonal antibodies that block Epstein-Barr virus from infecting human immune cells, marking a key milestone in

The Allen Institute has partnered with Anthropic to design and deploy custom autonomous AI agents that will accelerate bioscience research and help unlock new approaches

Seattle-based startup mpathic is expanding to help foundational model developers and LLM-powered application teams reduce dangerous responses and better protect vulnerable users. Founded in 2021

Lundbeck’s intravenous monoclonal antibody significantly reduced the number of monthly migraine days compared to placebo in a phase 2b study after the company had previously

AGC Biologics’ Seattle manufacturing facility has received Good Manufacturing Practices (GMP) certification from Brazil’s health regulatory authority, Agência Nacional de Vigilância Sanitária, enabling biologics and

A new vaccine designed to protect against multiple coronaviruses, including COVID-19, has entered human clinical testing after being developed using technology from the University of

London-based Tenpoint Therapeutics, which has its U.S. headquarters in Seattle, raised $235 million as it prepares to launch its lead eye drop treatment for presbyopia.

The Brotman Baty Institute and the Seattle Hub for Synthetic Biology have selected the first eight postdoctoral researchers for the SeaBridge Fellowship, a new translational

The Gates Foundation and OpenAI are launching a $50 million partnership to deploy artificial intelligence tools in frontline primary health care clinics across Africa, beginning

Pacific Northwest Research Institute (PNRI) researchers have shown that two harmful genetic variants can restore normal function when present together, experimentally validating a decades-old hypothesis